9 edition of Kynurenines in the brain found in the catalog.
by Nova Science Publishers in Hauppauge, NY
Includes bibliographical references and index.
|Statement||László Vécsei, editor.|
|LC Classifications||RC386.2 .K96 2005|
|The Physical Object|
|LC Control Number||2005010223|
Kynurenine, the breakdown product of tryptophan, has been shown to readily cross the blood-brain barrier (Fukui, Schwarcz, Rapoport, Takada, & Smith, ), where it is further metabolized to generate neuroactive glutamatergic compounds, namely, kynurenic acid or quinolinic acid, that act in an opposite manner. Schizophrenia, which affects around 1% of the world’s population, has been described as a complex set of symptoms triggered by multiple factors. However, the exact background mechanisms remain to be explored, whereas therapeutic agents with excellent effectivity and safety profiles have yet to be developed. Kynurenines and the endocannabinoid system Author: Ferenc Zádor, Gábor Nagy-Grócz, Gabriella Kekesi, Szabolcs Dvorácskó, Edina Szűcs, Csaba Tömböly, Gy.
Kynurenines in the Brain – From Experiments to Clinics Kynurenines in the Brain – From Experiments to Clinics Jellinger, K. A. László Vécsei, ed. Nova Biomedical Books, New York, , pp., hardcover, US$ , ISBN Recent scientific evidence has linked exotoxic cell death to the pathogenesis of both acute and . Vécsei, L. () Kynurenines in the Brain: From Experiments to Clinics. New York: Nova Biomedical Books. Google Scholar. Vécsei, L., Beal, M. () Intracerebroventricular injection of kynurenic acid, but not kynurenine, induces ataxia and stereotyped behavior in by:
The kynurenine pathway is a metabolic pathway leading to the production of nicotinamide adenine dinucleotide (NAD+) from the degradation of the essential amino acid tryptophan. Disruption in the pathway is associated with certain genetic disorders. 1 Kynurenine pathway dysfunction. Hydroxykynureninuria. Acquired and inherited enzyme. Trp enters the brain by carrier-mediated transport across the blood-brain barrier and is a precursor to serotonin. Thus, plasma Trp can affect cerebral serotonin synthesis. Levels of IDO and TDO are low in the brain and generation of kynurenines in the brain depends on availability of the downstream metabolite by:
Explore Dorset,its coast, countryside and heritage
Chicago (Access Guides)
Church of St. Breoke, Wadebridge
The long-nosed princess
law of tithes.
Art of the State 1996
Tales from Indian classics
Cherry gambol and other stories
Folktales of England
American sports (1785-1835).
Quinolinic Acid and the Kynurenines: Medicine & Health Science Books @ ed by: The NMDA receptor activation has been implicated in many neurological disorders such as stroke, brain injury, Parkinson’s disease, Huntington’s disease and multiple sclerosis. The receptor antagonists reduce the excitotoxic damage both in vivo 1,2,3 and in vitro 4 and could be used against neurodegenerative by: Topics covered include: kynurenines in the CNS, kynurenine and lysosomal proteolysis, pharmacology of the kynurenine pathway, retinal actions of quinolinic and kynurenic acids, behavioral and convulsive effects, the affective disorders, skin, hepatic encephalopathy, and invertebrates.
Annotation copyrighted by Book News, Inc., Portland, OR. In rodents, the fetal brain contains remarkably high concentrations of neuroactive kynurenines compared to the adult brain (Ceresoli-Borroni and Schwarcz, ), and a similar observation has been made with regard to prenatal cerebral kynurenic acid levels in non-human primates (Beal et al., ).
As the brain content of all these metabolites falls off precipitously immediately after birth, the high fetal brain Cited by: Moreover, kynurenine pathway metabolism itself is modulated in conditions such as infection and stress, which are known to induce major changes in well-being and behaviour, so that kynurenines may be instrumental in the etiology of psychiatric and neurological disorders.
It is therefore likely that the near future will not only witness the discovery of additional Cited by: The neuroactivities of kynurenines — the endogenous metabolites of tryptophan have been studied in our laboratory since the begin of ies (ref.
Cited by: The flux through the KP in brain is rate limited by IDO, a cytoplasmic enzyme that converts tryptophan to the catabolism products collectively known as kynurenines.
IDO is a heme enzyme found in the central nervous system (CNS) which has high affinity for L-tryptophan (mM) and requires oxygen [ 8, 9 ] for its by: Title: Kynurenines in the Central Nervous System: Recent Developments VOLUME: 7 ISSUE: 1 Author(s):Hajnalka Nemeth, Hermina Robotka, Jozsef Toldi and Laszlo Vecsei Affiliation:Department of Neurology,University of Szeged, POBH Szeged, Hungary.
Keywords:Kynurenic acid, quinolinic acid, excitotoxicity, neuroprotection Abstract: The Cited by: Numerous studies since the s have demonstrated that kynurenines can influence brain function.
The past years have witnessed a surge in new information regarding the roles of kynurenine pathway metabolites not only in brain physiology but also as potential causative factors in several devastating brain by: The kynurenine pathway is an effective mechanism in modulating the immune response and in inducing immune tolerance.
This is achieved by accelerating the degradation of tryptophan and the generation of kynurenines. The metabolites of the pathway, with their different inherent properties, can also synergize or antagonize the effects of one by: ISBN: OCLC Number: Description: vi, pages: illustrations (some color) ; 27 cm: Contents: Metabolism, analytical chemisty and possible role of kynorenine [sic] metabolites in disorders of the central nervous system --The analysis of kynurenine and its metabolites / Arvidsson, B., Bergquist, J.
--Kynurenine aminotransferase:. Notably, although neurons do have the ability to synthesize kynurenines (Guillemin et al., ), the local production of kynurenines in the mammalian brain takes place largely in nonneuronal cells.
Of these, microglial cells, which lack KATs but contain all enzymes that are involved in the successive conversion of kynurenine to QUIN, are believed to normally account for the local. The kynurenine pathway is commonly segregated into two distinct branches that are regulated by KATs and KMO, as well as the availability of l-kynurenine within the brain.
The kynurenine pathway can be stimulated in the brain by treatment with IFN-α. These findings point to the production of quinolinic acid by the kynurenine pathway as a contributing factor to neurodegenerative diseases which are associated with by: In brain, the tryptophan degradation products through the kynurenine pathway exhibit neuromodulatory and inflammatory effects and have been related to the progression of neurodegenerative disorders, furthermore, their protagonism on the modulation of immune response and in cancer development has been reported.
The immunosuppressive role of kynurenines Author: Gustavo Ignacio Vázquez Cervantes, Nora Karen OlascoagaArellano, Daniela Ramírez Ortega, Alelí Salaz. The kynurenine pathway.
Via the kynurenine pathway, TRP is converted to nicotinamide adenine dinucleotide (NAD) in a series of biochemical steps. In the. Accumulations of these neuroactive metabolites have been implicated in a number of neurodegenerative, convulsant and neurologic diseases, including complex partial seizures, HIV-associated neurologic disease, as well as a broad spectrum of inflammatory conditions that result from microbiological infections, autoimmune processes and brain injury Cited by: Our results indicate that the novel methodology, which allowed the measurement of extracellular kynurenine and 3-HK in the brain in vivo, will facilitate studies of brain kynurenines and of the interplay between peripheral and central kynurenine pathway function under physiological and pathological by: Worldwide, 50 million people suffer from dementia, a group of symptoms affecting cognitive and social functions, progressing severely enough to interfere with daily life.
Alzheimer’s disease (AD) accounts for most of the dementia cases. Pathological and clinical findings have led to proposing several hypotheses of AD pathogenesis, finding a presence of positive feedback Author: Masaru Tanaka, Zsuzsanna Bohár, László Vécsei. Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage.
Journal of Neural Transmission(2), DOI: /s Nikoletta Szabó, Zsigmond Tamás Kincses, József Toldi, Laszló by:. Kynurenines and cognitive function A direct examination of the effects of kynurenines on brain neurochemistry and behaviour in experimental animals and their roles in cognitive disorders in human patients has supported the view that this pathway plays a key role not only in several aspects of cognitive function but also in mediating the effects of environmental influences on Cited by: T cell apoptosis was observed at relatively low concentrations of kynurenines, did not require Fas/Fas ligand interactions and was associated with the activation of casapase-8 and the release of cytochromecfrom mitochondria.
In vivo, the two kynurenines caused depletion of specific thymocyte subsets in a fashion qualitatively similar to Cited by: The majority of the dietary tryptophan is degraded via the kynurenine pathway to kynurenine and other downstream tryptophan metabolites, together termed “kynurenines”.
The induction of the kynurenine pathway in the context of infections is currently the Cited by: 1.